NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.73
+0.64 (3.74%)
Nov 22, 2024, 4:00 PM EST - Market closed
NovoCure Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -149.78 | -207.04 | -92.53 | -58.35 | 19.81 | -7.23 | Upgrade
|
| Depreciation & Amortization | 9.58 | 9.7 | 9.57 | 9.17 | 7.75 | 6.78 | Upgrade
|
| Other Amortization | 4.59 | 4.59 | 4.35 | 4.42 | 5.91 | 1.84 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.9 | 0.49 | 0.96 | 0.65 | 0.43 | 0.4 | Upgrade
|
| Loss (Gain) From Sale of Investments | -26.4 | -26.4 | -4.83 | -0.24 | -1.25 | -2.33 | Upgrade
|
| Stock-Based Compensation | 114.72 | 115.61 | 106.96 | 94.9 | 75.72 | 52.42 | Upgrade
|
| Other Operating Activities | -4.98 | 0.07 | -5.47 | 3.14 | -0.7 | -0.92 | Upgrade
|
| Change in Accounts Receivable | -3.66 | 29.41 | 2.55 | 5.27 | -30.35 | -36.5 | Upgrade
|
| Change in Inventory | -1.54 | -8.92 | -4.34 | 2.48 | -2.94 | -1.16 | Upgrade
|
| Change in Accounts Payable | 17.62 | 14.87 | 14.26 | 27.78 | 25.47 | 16.88 | Upgrade
|
| Change in Other Net Operating Assets | 1.48 | -5.71 | -0.67 | -6.46 | -0.7 | -3.56 | Upgrade
|
| Operating Cash Flow | -37.48 | -73.34 | 30.79 | 82.76 | 99.15 | 26.62 | Upgrade
|
| Operating Cash Flow Growth | - | - | -62.80% | -16.53% | 272.46% | - | Upgrade
|
| Capital Expenditures | -40.73 | -27.09 | -21.36 | -24.17 | -14.97 | -10.49 | Upgrade
|
| Investment in Securities | 21.2 | 211.24 | -118.6 | -120.66 | -457.88 | -41.18 | Upgrade
|
| Investing Cash Flow | -19.53 | 184.15 | -139.96 | -144.83 | -472.85 | -51.67 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 558.44 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.01 | -0.03 | -0.03 | -150.03 | -0.03 | Upgrade
|
| Net Debt Issued (Repaid) | 84.01 | -0.01 | -0.03 | -0.03 | 408.41 | -0.03 | Upgrade
|
| Issuance of Common Stock | 5.53 | 15.8 | 15.52 | 25.73 | 31.8 | 61.71 | Upgrade
|
| Financing Cash Flow | 89.54 | 15.79 | 15.49 | 25.7 | 440.21 | 61.68 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.15 | 0.13 | -0.1 | -0.19 | 0.25 | 0.03 | Upgrade
|
| Net Cash Flow | 32.69 | 126.73 | -93.78 | -36.56 | 66.76 | 36.66 | Upgrade
|
| Free Cash Flow | -78.21 | -100.43 | 9.43 | 58.59 | 84.18 | 16.14 | Upgrade
|
| Free Cash Flow Growth | - | - | -83.90% | -30.40% | 421.72% | - | Upgrade
|
| Free Cash Flow Margin | -13.54% | -19.72% | 1.75% | 10.95% | 17.03% | 4.59% | Upgrade
|
| Free Cash Flow Per Share | -0.73 | -0.94 | 0.09 | 0.57 | 0.77 | 0.17 | Upgrade
|
| Cash Interest Paid | 4.94 | 0.01 | 0.04 | 0.1 | 8.69 | 13.7 | Upgrade
|
| Cash Income Tax Paid | 21.97 | 13.67 | 5.48 | 3.11 | -3.26 | 11.24 | Upgrade
|
| Levered Free Cash Flow | 0.82 | -10.2 | 51.76 | 104.89 | 66.98 | 24.89 | Upgrade
|
| Unlevered Free Cash Flow | 2.86 | -11.44 | 50.55 | 103.7 | 73.45 | 33.41 | Upgrade
|
| Change in Net Working Capital | -11.89 | -30.43 | -9.9 | -50.03 | 15.71 | 16.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.